FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:324-326 July 22, 2004 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Pallais, J. C. PubMed Citation

We live in the era of the Human Genome Project, human and mouse genetics, proteomics, evidence-based medicine, intelligent drug design, and a new "road map" for the National Institutes of Health (NIH) that relies on multidisciplinary, translationally directed teams of basic scientists and clinicians focused on specific goals related to human health. Nonetheless, it is rare indeed that an unanticipated discovery in basic science leads within a decade to the development and commercialization of an entirely new therapeutic class of agents.

It has been known for decades that serum calcium regulates the secretion of parathyroid hormone by the parathyroid glands . . . [Full Text of this Article]

Source Information

From the Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh.

This article has been cited by other articles:

• Horwitz, M. J., Stewart, A. F. (2008). Hypoparathyroidism: Is It Time for Replacement Therapy?. J. Clin. Endocrinol. Metab. 93: 3307-3309 [Full Text]  
• Hu, J., McLarnon, S. J., Mora, S., Jiang, J., Thomas, C., Jacobson, K. A., Spiegel, A. M. (2005). A Region in the Seven-transmembrane Domain of the Human Ca2+ Receptor Critical for Response to Ca2+. J. Biol. Chem. 280: 5113-5120 [Abstract] [Full Text]  
• Seeman, E., Strewler, G. J. (2004). Clinical and Basic Research Papers - July 2004 Selections. IBMS BoneKEy 1: 1-5 [Full Text]